Skip to content
Catalyst

luteinFinding

Lutein increases macular pigment optical density

raisesVery limited evidenceFindingreplicated ×3

01 · The sentence it was drawn from

“There was a significant group by time interaction for MPOD (F = 6.74, P = 0.02), skin carotenoids (F = 17.30, P < 0.01), and serum lutein (F = 24.10, P < 0.01), whereby the treatment group improved in all carotenoid outcomes.”
Quoted verbatim from Randomized, Placebo-Controlled, Single-Blind Study of Lutein Supplementation on Carotenoid Status and Cognition in Persons with Multiple Sclerosis.
This finding among the 6 findings on its endpoint

lutein

Macular pigment optical density

raises

Who
adults with relapsing-remitting multiple sclerosis; MPOD by heterochromatic flicker photometry
Dose studied
lutein 20 mg/day for 4 months

Very limited evidencePMID 37364683 · 2023

02 · The study

Study
RCT
Duration
not reported

Evidence, by strength

  • strong
  • moderate
  • limited
  • very limitedthis finding
  • insufficient

04 · To cite this finding

This address does not change

https://catalystproject.ai/e/01M6Y4N768JGGNQ932KWRDH1Q0